Added to Email Alerts

Psoriatic Arthritis

Latest News View All

ACR 2020

After Methotrexate Failure, Is JAK Inhibitor or Biologic Next?

Medscape Medical News November 23, 2020
AHA 2020

Chronic Inflammatory Diseases Vary Widely in CHD Risk

Medscape Medical News November 16, 2020
ACR 2020

Tofacitinib Effective for Ankylosing Spondylitis in Phase 3

Medscape Medical News November 10, 2020
Guselkumab Improvements for PsA Persist Through 1 Year

Medscape Medical News October 16, 2020
Experts Assess Infection Risks for Patients on Biologics

Medscape Medical News October 8, 2020
Pregnancy Studies on Psoriasis, PsA Medications Pick Up

Medscape Medical News October 2, 2020
FDA Expands Polyarticular-Course JIA Indications for Tofacitinib

FDA Approvals October 1, 2020
Aspirin for Primary Prevention of CVD in Rheumatic Diseases

Medscape Medical News September 22, 2020

View All

Perspective View All

ACR 2020

Conference Coverage November 5, 2020

Read clinically focused news coverage of key developments from ACR 2020
COVID-19 in People with Arthritis

ReCAP Guidance May 22, 2020
ACR 2019

Conference Coverage November 7, 2019
Psoriasis and IBD: Is This Comorbidity for Real?

Viewpoint January 11, 2019

View All

Journal Articles View All

Dermatologic Applications and Safety of JAK Inhibitors

Skin Therapy Letter November 20, 2020
Ixekizumab Treatment of Biologic-Naive Psoriatic Arthritis

Rheumatology November 2, 2020
Efficacy and Tolerability of Biologic Therapies in Psoriasis

The British Journal of Dermatology October 29, 2020
Guidelines for Biologic Therapy for Psoriasis 2020

The British Journal of Dermatology October 22, 2020
Lymphoma Risk With Anti-TNF Agents and/or Thiopurines in IBD

Alimentary Pharmacology & Therapeutics October 21, 2020
Life Experiences of Psoriasis Patients Receiving Biologics

The British Journal of Dermatology October 16, 2020

View All